Battleman D[au] - Search Results

Year	Number of Results
1992	1
1993	1
1995	1
1996	2
2001	2
2002	3
2003	1
2004	2
2005	2
2006	1
2008	2
2009	7
2010	5
2024	0

1

Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications.

Petrilla AA, Benner JS, Battleman DS, Tierce JC, Hazard EH. Petrilla AA, et al. Among authors: battleman ds. Int J Clin Pract. 2005 Dec;59(12):1441-51. doi: 10.1111/j.1368-5031.2005.00704.x. Int J Clin Pract. 2005. PMID: 16351677 Review.

2

Mechanism of repetitive monomorphic ventricular tachycardia.

Lerman BB, Stein K, Engelstein ED, Battleman DS, Lippman N, Bei D, Catanzaro D. Lerman BB, et al. Among authors: battleman ds. Circulation. 1995 Aug 1;92(3):421-9. doi: 10.1161/01.cir.92.3.421. Circulation. 1995. PMID: 7634458

3

Intracoronary stents.

Jauhar R, Battleman DS, Altmann DB, Parikh M, Flyer J, Autz L, Sanborn TA. Jauhar R, et al. Among authors: battleman ds. Surg Technol Int. 1996;5:283-9. Surg Technol Int. 1996. PMID: 15858753

4

Receptors for nerve growth factor.

Chao MV, Battleman DS, Benedetti M. Chao MV, et al. Among authors: battleman ds. Int Rev Cytol. 1992;137B:169-80. doi: 10.1016/s0074-7696(08)62604-2. Int Rev Cytol. 1992. PMID: 1478819 Review. No abstract available.

5

Appropriate VTE prophylaxis is associated with lower direct medical costs.

Amin A, Hussein M, Battleman D, Lin J, Stemkowski S, Merli GJ. Amin A, et al. Among authors: battleman d. Hosp Pract (1995). 2010 Nov;38(4):130-7. doi: 10.3810/hp.2010.11.350. Hosp Pract (1995). 2010. PMID: 21068537

6

Predictors of adherence with antihypertensive and lipid-lowering therapy.

Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, Schwartz JS. Chapman RH, et al. Among authors: battleman ds. Arch Intern Med. 2005 May 23;165(10):1147-52. doi: 10.1001/archinte.165.10.1147. Arch Intern Med. 2005. PMID: 15911728

7

Cost of atrial fibrillation in United States managed care organizations.

Kim MH, Lin J, Hussein M, Kreilick C, Battleman D. Kim MH, et al. Among authors: battleman d. Adv Ther. 2009 Sep;26(9):847-57. doi: 10.1007/s12325-009-0066-x. Epub 2009 Sep 19. Adv Ther. 2009. PMID: 19768638

8

Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.

Johnson ML, Pietz K, Battleman DS, Beyth RJ. Johnson ML, et al. Among authors: battleman ds. Am J Manag Care. 2004 Dec;10(12):926-32. Am J Manag Care. 2004. PMID: 15617368 Free article.

9

Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation.

Kim MH, Klingman D, Lin J, Pathak P, Battleman DS. Kim MH, et al. Among authors: battleman ds. Ann Pharmacother. 2009 May;43(5):840-8. doi: 10.1345/aph.1L698. Ann Pharmacother. 2009. PMID: 19417111

10

Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation.

Kim MH, Lin J, Hussein M, Battleman D. Kim MH, et al. Among authors: battleman d. Curr Med Res Opin. 2009 May;25(5):1215-20. doi: 10.1185/03007990902869235. Curr Med Res Opin. 2009. PMID: 19327101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year